WE’RE GROWING NEWDIGS searching for new director, program manager We’re searching for Director and Program manager talent—join our interdisciplinary think-and-do tank designing solutions to make biopharma and healthcare systems more … Read More
LEAPS leadership news: Kay Larholt retires, Fotios Kokkotos joins
In February 2022, Kay Larholt retired from her role as Director of Research for NEWDIGS, to stay on as a Senior Advisor. Fotios Kokkotos joined as NEWDIGS’ Director of Data … Read More
Broadly Engaged Team Science Comes to Life in a Design Lab
The objective of broadly engaged team science is to bring a diverse group of stakeholders into a project early and continue to include their expertise throughout to inform and propel … Read More
Data for modelling US projections of product approvals, patients treated, and product revenues for durable cell and gene therapies
Data in Brief, 41, 107891.Young, C. M., Trusheim, M., & Quinn, C. (2022). The recent marketing approval of several durable gene and cell therapies (2017-2020), together with observations that 7,000 … Read More
FoCUS Monthly Recap: January 2022
JUST RELEASED Paying for Cures Toolkit updated with new pipeline modeling and financing strategies Today FoCUS released an updated and expanded version of its Paying for Cures Toolkit, which is designed … Read More
LEAPS Monthly Recap: January 2022
RECENT PUBLICATION LEAPS research in Precision Reimbursement published in Clinical Pharmacology & Therapeutics The article, “Precision Reimbursement for Precision Medicine: Using Real-World Evidence to Evolve From Trial-and-Project to Track-and-Pay to Learn-and-Predict,” appeared … Read More
Durable cell and gene therapy potential patient and financial impact: US projections of product approvals, patients treated, and product revenues
Drug Discovery Today (2021). DOI: 10.1016/j.drudis.2021.09.001C. Young; C. Quinn; M. Trusheim. Durable cell and gene therapies potentially transform patient lives, but payers fear unsustainable costs arising from the more than … Read More
FoCUS Monthly Recap: December 2021
COMING SOON Paying for Cures Toolkit update in early ’22 After the holiday FoCUS will release a major update to the toolkit, including updates to the Pipeline and Individual Indication worksheets … Read More
LEAPS Monthly Recap: December 2021
DESIGN LAB REPORT LEAPS Design Lab advances pilot projects At the November 30 and December 1 Design Lab participants shaped the designs for three pilots to launch in 2022. … Read More
LEAPS Monthly Recap: October 2021
NEW MEMBER Flatiron Health joins LEAPS Project This month, Flatiron Health, the clinical and science data healthtech company dedicated to helping cancer centers thrive and deliver better care for patients today … Read More